| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT03907475 Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid… |
date change Primary completion pushed: 2026-06-01 -> 2027-06-01 |
| 2026-06-12 | NCT03907475 Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid… |
date change Completion pushed: 2026-06-01 -> 2027-06-01 |
| 2026-06-12 | NCT05548296 A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma |
Enrollment reduced: 401 -> 350 participants |
| 2026-06-12 | NCT04491942 Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT04491942 Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT03321643 Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT03321643 Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-11 | NCT03295383 Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-11 | NCT03295383 Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral… |
Enrollment reduced: 130 -> 92 participants |
| 2026-06-11 | NCT06835569 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With… |
Enrollment increased: 188 -> 448 participants |
| 2026-06-11 | NCT06835569 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With… |
Trial arms changed: 2 -> 10 |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
Enrollment increased: 700 -> 800 participants |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
Trial sites expanded: 314 -> 317 locations |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
date change Primary completion moved earlier: 2028-01-20 -> 2027-10-15 |
| 2026-06-11 | NCT07015242 A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line… |
Trial sites reduced: 82 -> 40 locations |
| 2026-06-11 | NCT07379047 Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors… |
Recruitment opened |
| 2026-06-11 | NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… |
Trial sites expanded: 286 -> 290 locations |
| 2026-06-11 | NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… |
date change Primary completion pushed: 2028-01-31 -> 2028-09-25 |
| 2026-06-11 | NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… |
date change Completion pushed: 2031-08-31 -> 2032-04-25 |
| 2026-06-11 | NCT05100862 A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants… |
Sponsor changed: BeiGene -> BeOne Medicines |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07638787 Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL | Phase 1/2 | Not Yet Recruiting |
| 2026-06-10 | NCT07639528 Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted… | Phase 2 | Not Yet Recruiting |
| 2026-06-10 | NCT07640048 Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study | Recruiting | |
| 2026-06-09 | NCT07635342 Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer | Phase 2 | Recruiting |
| 2026-06-09 | NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Phase 2 | Not Yet Recruiting |
| 2026-06-08 | NCT07634471 A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | Phase 2/3 | Not Yet Recruiting |
| 2026-06-02 | NCT07619313 AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients… | Phase 1 | Not Yet Recruiting |
| 2026-06-02 | NCT07621718 Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of… | Phase 3 | Recruiting |
| 2026-06-01 | NCT07616362 Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With… | Phase 2 | Not Yet Recruiting |
| 2026-06-01 | NCT07619235 A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination… | Phase 4 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05898308 | Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus | Pemphigus | Recruiting |
| NCT06831370 | A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults… | Hodgkin Lymphoma | Recruiting |
| NCT06031233 | Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie | Oncology | Recruiting |
| NCT06457503 | A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With… | Nasopharyngeal Cancer Recurrent | Recruiting |
| NCT07451847 | Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive… | ANCA Associated Vasculitis (AAV) | Not Yet Recruiting |
| NCT07010302 | Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD | NMOSD | Not Yet Recruiting |
| NCT07619235 | A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination… | Biliary Tract Cancer (BTC) | Not Yet Recruiting |
| Phase 3 | |||
| NCT06220032 | Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With… | DLBCL - Diffuse Large B Cell Lymphoma | Recruiting |
| NCT07189455 | Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With… | Small-cell Lung Cancer | Recruiting |
| NCT07218809 | AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low… | Epithelial Ovarian Cancer | Recruiting |
| NCT07362914 | Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions | Breast Cancer | Recruiting |
| NCT07229625 | A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing… | Advanced Biliary Tract Cancer | Recruiting |
| NCT06983821 | Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis… | Granulomatosis With Polyangiitis | Recruiting |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in… | Metastatic HER2-positive Breast Cancer | Recruiting |
| NCT06752811 | Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer | Pancreatic Cancer Metastatic | Recruiting |
| NCT03126916 | Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With… | Ganglioneuroblastoma | Recruiting |
| NCT06239727 | Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment… | Nasopharyngeal Carcinoma | Recruiting |
| NCT07459296 | Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT07409428 | A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory… | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT06072781 | A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous… | Low Grade Serous Ovarian Cancer | Recruiting |
| NCT04871191 | Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis | Granulomatosis With Polyangiitis | Recruiting |
| NCT07509840 | Immunomodulatory Therapy to Restore Ovarian Function and Improve Fertility in Women With… | Autoimmune Prematur Ovarian Insuffience | Recruiting |
| NCT06522737 | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With… | Lymphoma | Recruiting |
| NCT07418749 | A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With… | Recurrent Cervical Cancer | Recruiting |
| NCT07441460 | A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable… | Resectable HER2-positive Breast Cancer | Recruiting |